Med Immune entered the industry of Serums and Vaccines Manufacturers in 0 and has grown to employ 1 to 4 people, generating an annual revenue of $20.000.000 to $49.9999.999. The NAICS classifies this business under the code 3254140, which describes it as a Serums and Vaccines Manufacturers. For further clarification, the SIC classifies this business under the code 2836 and described it as a Serums and Vaccines Manufacturers. The business provides service to the B2B market.
To acquire more information, please contact by calling (215) 501-1300 during business hours. You can also write to the business’ Branch at 3001 Red Lion Road, Philadelphia, Pennsylvania PA 19114. You can also visit the company’s website at medimmune.com. View this business’ social media profiles on Twitter or on Facebbok .
| Company: | Med Immune |
| Place of Business: | 3001 Red Lion Road, Philadelphia, PA 19114 |
| Contact Number: | (215) 501-1300 |
| Website: | medimmune.com |
| Type of Service: | Serums and Vaccines Manufacturers |
| SIC Number: | 2836 |
| NAICS Number: | 3254140 |
| Locality: | Branch |
| Market Type: | B2B (Business to Business) |
| Income/Year: | $20.000.000 to $49.9999.999 |
| Laborers: | 1 to 4 |
| Share This Company: |
Med Immune is a company operating from Philadelphia, Pennsylvania providing professional Serums and Vaccines Manufacturers and relevant B2B variables. It was founded in 0 and registered with the SIC code 2836 as Serums and Vaccines Manufacturers, and with the NAICS code 3254140 as Serums and Vaccines Manufacturers.
With a current employee count of 1 to 4, Med Immune has gone to report making $20.000.000 to $49.9999.999 per annum on its journey towards growth. This company invites you to contact its representative at (215) 501-1300 for related queries, or to locate its Branch using the coordinates 40.08391,-75.00186.
The Branch can also be found at the street address 3001 Red Lion Road in Philadelphia, Pennsylvania 19114 and can be engaged online through the company website at medimmune.com, the company Twitter , and Facebook page .